Skip to main content
. 2017 Sep 5;17(12):3219–3227. doi: 10.1111/ajt.14452

Figure 1.

Figure 1

Study design. CsA, cyclosporine; LI, less intensive; MI, more intensive. *All patients received basiliximab induction, mycophenolate mofetil, and corticosteroid taper